Compare RLAY & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | EH |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2020 | 2019 |
| Metric | RLAY | EH |
|---|---|---|
| Price | $9.15 | $11.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $15.75 | ★ $21.85 |
| AVG Volume (30 Days) | ★ 2.5M | 694.9K |
| Earning Date | 02-24-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,355,000.00 | ★ $60,400,607.00 |
| Revenue This Year | $19.96 | $10.53 |
| Revenue Next Year | N/A | $81.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.39 |
| 52 Week Low | $1.78 | $11.23 |
| 52 Week High | $9.25 | $29.76 |
| Indicator | RLAY | EH |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 37.37 |
| Support Level | $8.08 | $11.23 |
| Resistance Level | $9.25 | $12.43 |
| Average True Range (ATR) | 0.67 | 0.45 |
| MACD | 0.12 | -0.09 |
| Stochastic Oscillator | 83.02 | 25.32 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.